Beyond tumor control: symptom trajectories and hearing outcomes after contemporary Gamma Knife radiosurgery for vestibular schwannoma
Journal of Neuro-Oncology · 2026-07 · 178 (3)
DOI: 10.1007/s11060-026-05682-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro-Oncology, online erschienen am 23.06.2026. Verfasst von Jheremy S Reyes und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Image-Guided Neurosurgery, Department of Neurological Surgery, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA. Hauptthemen laut MEDLINE: Radiosurgery, Neuroma, Acoustic, Hearing Loss, Hearing. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Gamma Knife radiosurgery (GKRS) is an established treatment for vestibular schwannoma, but contemporary cohort-level data integrating long-term tumor control with clinical symptom trajectories and hearing-related correlates remain valuable. METHODS: We performed a retrospective cohort study of 286 patients with vestibular schwannoma (VS) treated with GKRS (2014-2024). The primary endpoint was local control. Secondary outcomes included overall survival and changes in hearing loss, imbalance, vertigo, dizziness, and tinnitus. Kaplan-Meier analysis was used to estimate local control and overall survival. Paired symptom changes were assessed using McNemar testing. RESULTS: The Median follow-up was 52.3 months (IQR 27.4-80.3). Progressive radiographic enlargement occurred in 5 patients, yielding a crude local control rate of 98.3%. The actuarial local control was 98.5% at 5 years and 96.5% at 10 years. Imbalance, vertigo, dizziness, and tinnitus improved significantly after GKRS, whereas hearing loss remained stable overall (59.4% vs. 57.3%, p = 0.441). Mean symptom burden declined from 1.74 to 1.20 symptoms per patient (p 2.9-3.6 Gy, 66.2% for > 3.6-4.5 Gy, and 73.8% for > 4.5 Gy (p = 0.00012). Baseline hearing loss remained the strongest predictor in multivariable modeling. CONCLUSIONS: At a median of four years GKRS provided tumor control in > 95% of VS patients and was associated with reduced overall symptom burden and improvement in vestibular symptoms. Hearing outcomes were related to baseline auditory status, Koos grade, and cochlear dosimetry. CLINICAL TRIAL NUMBER: Not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Image-Guided Neurosurgery, Department of Neurological Surgery, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA.
- Center for Image-Guided Neurosurgery, Department of Neurological Surgery, University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA. niraax@upmc.edu.
Zitieren
APA
Reyes, J. S., Hadjipanayis, C. G., Lunsford, L. D., & Niranjan, A. (2026). Beyond tumor control: symptom trajectories and hearing outcomes after contemporary Gamma Knife radiosurgery for vestibular schwannoma. Journal of Neuro-Oncology, 178(3). https://doi.org/10.1007/s11060-026-05682-5
Vancouver
Reyes JS, Hadjipanayis CG, Lunsford LD, Niranjan A. Beyond tumor control: symptom trajectories and hearing outcomes after contemporary Gamma Knife radiosurgery for vestibular schwannoma. Journal of Neuro-Oncology. 2026;178(3). doi:10.1007/s11060-026-05682-5
BibTeX
@article{Reyes2026,
author = {Reyes, Jheremy S and Hadjipanayis, Constantinos G and Lunsford, L Dade and Niranjan, Ajay},
title = {Beyond tumor control: symptom trajectories and hearing outcomes after contemporary Gamma Knife radiosurgery for vestibular schwannoma},
journal = {Journal of Neuro-Oncology},
year = {2026},
volume = {178},
number = {3},
doi = {10.1007/s11060-026-05682-5}
}
EUVIMED